1) How important is the DIA Conference in Philadelphia for Take
solutions?
Extremely important. The 42nd Annual DIA conference is a big event with over 350 sessions, 475 exhibiting companies, more than 1000 speakers, and approximately 40 tutorials. Kimberly Warner, Director Operations at TAKE-ACI and Dr. Jonathan Seltzer, President of ACI will be speaking at the event. TAKE will occupy a booth on the floor and plans to display the PharmaReady and OneClinical offerings.
(2) Will the two suites give an edge for your company and how?
We are the only player in the marketplace who is “talking about enabling end-to-end efficiencies in the Life Sciences space” and also “doing something about it”. Our vision for the LS marketplace with our PharmaReady and OneClinical portfolio offerings will assist pharmaceutical and bio-tech companies to leverage our software products and also engage our domain experts for providing the best possible advice to take a drug to market. We understand the drug development process and the regulatory aspects involved and hence are better suited to address these needs of our customers.
(3) What is next coming up with Take solutions?
We will continue to seed our flagship products, PharmaReady and OneClinical with value added offerings to the LS customers and build the “critical mass” of confidence and trust that is so vital to this industry segment.
